International Medical News Group has been acquired by Quadrant HealthCom Inc.
Reed Elsevier Group Plc has sold International Medical News Group (IMNG), the leading provider of medical news, to Quadrant HealthCom Inc. (Quadrant), which is owned by the investment firm M.E. Zukerman, forming Frontline Medical Communications, under which the two entities will operate their individual brands. Combined, company revenues are now over US$60 million. Financial terms of this transaction have not been disclosed.
IMNG President and CEO, Alan Imhoff, will remain in his role, joining Quadrant President and CEO, Marcy Holeton, Custom Solutions President, JoAnn Wahl and CFO, Doug Grose, in a combined "Office of the President" which will oversee company operations. Stephen Stoneburn will become chairman of Frontline Medical Communications.
New Jersey-based Quadrant is a multimedia communications company specializing in the healthcare market, publishing 13 medical journals, 24 websites and 10 events. In late 2009, the company bought four medical journals in the Dowden Professional Publications group from Lebhar-Friedman. As a result of this acquisition, Quadrant greatly expands its brands and audience reach. Frontline Medical Communications will produce 29 publications in 17 market segments. The group will also publish 125 e-newsletters, 35 websites and 14 live events.
Reed Elsevier Group Plc operates as a professional information solutions provider in the UK and internationally.
Oaklins' media specialist team in New York advised the seller in this transaction.
Talk to the deal team
Roland A. DeSilva
Oaklins DeSilva+Phillips
Related deals
MJH Associates has acquired UBM Life Sciences’ healthcare media assets from Informa
MJH Associates‚ Inc. (MJH) has acquired major market media assets from the UBM Life Sciences Group of Informa PLC (INF.L). The transaction consideration was in excess of US$100 million.
Learn moreVersalinx has been acquired by DuckerFrontier
DuckerFrontier, a portfolio company of Boathouse Capital, has acquired Versalinx, a global provider of B2B events.
Learn moreSymbiotix, Inc. has been acquired by Havas Health, Inc.
Symbiotix, a US medical communications and marketing agency, has been sold to Paris-based Havas and has become part of Havas Health, a leading, global healthcare marketing network. Financial details were not disclosed. Symbiotix leverages science and strategy to engage physicians and other healthcare professionals (HCPs).
Learn more